Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,404 | 46,408 | 53,865 | 40,182 | 45,680 |
| TOTAL | $40,665 | $47,225 | $54,361 | $40,986 | $47,049 |
| Non-Current Assets | |||||
| PPE Net | 12,320 | 12,310 | 12,230 | 12,046 | 11,998 |
| Other Non-Current Assets | 2,100 | 2,140 | 2,106 | 1,794 | 1,811 |
| TOTAL | $14,421 | $14,450 | $14,336 | $13,840 | $13,809 |
| Total Assets | $55,086 | $61,675 | $68,696 | $54,826 | $60,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,350 | 2,664 | 3,309 | 7,634 | 6,215 |
| Accrued Expenses | 2,348 | 2,214 | 1,108 | 1,062 | 660 |
| Other current liabilities | 251 | 356 | 397 | 296 | 366 |
| TOTAL | $6,949 | $5,234 | $4,815 | $8,992 | $7,241 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,390 | 15,258 | 15,125 | 9,828 | 11,241 |
| TOTAL | $15,390 | $15,258 | $15,125 | $9,828 | $11,241 |
| Total Liabilities | $22,340 | $20,491 | $19,940 | $18,820 | $18,482 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11 | 11 | 11 | 11 | 9 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -160,828 | -151,417 | -142,930 | -134,392 | -127,547 |
| TOTAL | $32,746 | $41,183 | $48,757 | $36,006 | $42,376 |
| Total Liabilities And Equity | $55,086 | $61,675 | $68,696 | $54,826 | $60,858 |